Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Intranasal formulation of teriparatide may improve compliance

Oct. 28, 2013

Activity of AXL/c-Met inhibitor CEP-40783 described in vitro and in vivo

Oct. 28, 2013

ManNAc safe and well tolerated in phase I study in hereditary inclusion body myopathy

Oct. 25, 2013

Antibody-drug conjugate MLN-0264 targets GC-C expressed in pancreatic cancer

Oct. 25, 2013

Bayer Schering Pharma introduces new PET radiopharmaceuticals

Oct. 25, 2013

BPR-0C-305 displays oncolytic activity when administered orally

Oct. 25, 2013

AstraZeneca details discovery of AZ7732, a new dimeric pan-IAP inhibitor

Oct. 25, 2013

Mouse model created for genetic susceptibility to both dementia and Parkinson's disease

Oct. 24, 2013

Pharmacokinetics and pharmacodynamics determined for CW-002 in healthy volunteers

Oct. 24, 2013

ERP29, IKBKAP gene polymorphisms associated with breast cancer risk and clinical features

Oct. 24, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....